Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Bedimo

Showing results (41-50 of 88) with videos related to

Pageof 9
Sort By:
The Journal of Antimicrobial Chemotherapy|May 1, 2019
Comparable viral decay with initial dolutegravir plus lamivudine versus dolutegravir-based triple therapyJason Gillman, Patrick Janulis, Roy Gulick, et al.
Open Forum Infectious Diseases|September 23, 2022
Meta-Analysis: Outcomes of Surgical and Medical Management of Diabetic Foot OsteomyelitisDavid H Truong, Roger Bedimo, Matthew Malone, et al.
Pharmacotherapy|June 26, 2008
Safety and efficacy of simvastatin for the treatment of dyslipidemia in human immunodeficiency virus-infected patients receiving efavirenz-based highly active antiretroviral therapyAnita P Rahman, Susan A Eaton, Sean T Nguyen, et al.
AIDS (London, England)|June 4, 2024
Choice of antiretroviral therapy has low impact on weight gainHenning Drechsler, Colby Ayers, Ikwo Oboho, et al.
AIDS (London, England)|November 13, 2015
Mechanisms of bone disease in HIV and hepatitis C virus: impact of bone turnover, tenofovir exposure, sex steroids and severity of liver diseaseRoger Bedimo, James Cutrell, Song Zhang, et al.
The Journal of Infectious Diseases|August 21, 2018
Policy Recommendations for Optimizing the Infectious Diseases Physician-Scientist WorkforceUpinder Singh, Jaclyn Levy, Wendy Armstrong, et al.
Infectious Diseases and Therapy|March 2, 2018
Tenofovir-Associated Bone Adverse Outcomes among a US National Historical Cohort of HIV-Infected Veterans: Risk Modification by Concomitant AntiretroviralsJoanne LaFleur, Adam P Bress, Joel Myers, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|January 22, 2025
Management of a COVID-19 outbreak using a multidisciplinary approach and infection prevention control practices at a community living center in Veterans Administration Hospital, North TexasIkwo K Oboho, John Hanna, Denisse Silva-Rodriguez, et al.
Open Forum Infectious Diseases|June 19, 2019
Impact of Availability of Telehealth Programs on Documented HIV Viral Suppression: A Cluster-Randomized Program Evaluation in the Veterans Health AdministrationMichael E Ohl, Kelly Richardson, Maria C Rodriguez-Barradas, et al.
AIDS Research and Human Retroviruses|October 27, 2015
Effects of Pegylated Interferon/Ribavirin on Bone Turnover Markers in HIV/Hepatitis C Virus-Coinfected PatientsRoger Bedimo, Minhee Kang, Pablo Tebas, et al.
Pageof 9

Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
The Journal of Antimicrobial Chemotherapy|May 1, 2019
Comparable viral decay with initial dolutegravir plus lamivudine versus dolutegravir-based triple therapyJason Gillman, Patrick Janulis, Roy Gulick, et al.
Open Forum Infectious Diseases|September 23, 2022
Meta-Analysis: Outcomes of Surgical and Medical Management of Diabetic Foot OsteomyelitisDavid H Truong, Roger Bedimo, Matthew Malone, et al.
Pharmacotherapy|June 26, 2008
Safety and efficacy of simvastatin for the treatment of dyslipidemia in human immunodeficiency virus-infected patients receiving efavirenz-based highly active antiretroviral therapyAnita P Rahman, Susan A Eaton, Sean T Nguyen, et al.
AIDS (London, England)|June 4, 2024
Choice of antiretroviral therapy has low impact on weight gainHenning Drechsler, Colby Ayers, Ikwo Oboho, et al.
AIDS (London, England)|November 13, 2015
Mechanisms of bone disease in HIV and hepatitis C virus: impact of bone turnover, tenofovir exposure, sex steroids and severity of liver diseaseRoger Bedimo, James Cutrell, Song Zhang, et al.
The Journal of Infectious Diseases|August 21, 2018
Policy Recommendations for Optimizing the Infectious Diseases Physician-Scientist WorkforceUpinder Singh, Jaclyn Levy, Wendy Armstrong, et al.
Infectious Diseases and Therapy|March 2, 2018
Tenofovir-Associated Bone Adverse Outcomes among a US National Historical Cohort of HIV-Infected Veterans: Risk Modification by Concomitant AntiretroviralsJoanne LaFleur, Adam P Bress, Joel Myers, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|January 22, 2025
Management of a COVID-19 outbreak using a multidisciplinary approach and infection prevention control practices at a community living center in Veterans Administration Hospital, North TexasIkwo K Oboho, John Hanna, Denisse Silva-Rodriguez, et al.
Open Forum Infectious Diseases|June 19, 2019
Impact of Availability of Telehealth Programs on Documented HIV Viral Suppression: A Cluster-Randomized Program Evaluation in the Veterans Health AdministrationMichael E Ohl, Kelly Richardson, Maria C Rodriguez-Barradas, et al.
AIDS Research and Human Retroviruses|October 27, 2015
Effects of Pegylated Interferon/Ribavirin on Bone Turnover Markers in HIV/Hepatitis C Virus-Coinfected PatientsRoger Bedimo, Minhee Kang, Pablo Tebas, et al.
Pageof 9